The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

Learn more about:
Related Clinical Trial
Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer Retrospective Study of Brachytherapy Groningen International Study on Sentinel Nodes in Vulvar Cancer-III Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study Education, Immigration and HPV Vaccination: an Informational Randomized Trial Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years Serial MRI Scans During Radiation Therapy A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Cisplatin+Pembrolizumab+RT in Vulvar Cancer Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery MR-HIFU for Recurrent Gynaecological Cancer Pelvic Floor Disorders in Survivors of Gynecologic Malignancies Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life Paclitaxel Therapeutic Drug Monitoring in Cancer Patients Validation of a Nutrition Screening Tool A Survivorship Care Plan for Gynaecological Cancer Patients Self-Advocacy Serious Game in Advanced Cancer Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) Chemoradiation-Induced Nausea and Emesis: Quality of Life A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies ChemoFx® PRO – A Post-Market Data Collection Study Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Image-Guided Gynecologic Brachytherapy Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Topical Imiquimod in Treating Patients With Recurrent Paget’s Disease of the Vulva Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. The Impact of the “WOMAN-PRO II Program” on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence CaptHPV : Validation of the Method “CaptHPV” for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers Effectiveness of an Individualized Symptom Education Program (ISEP) A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer OCT-AF Imaging of Pre-cancers of Vulva and Cervix Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer Sentinel Node Extended in Squamous Cell Vulvar Cancer Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva

Brief Title

The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

Official Title

Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology

Brief Summary

      This study compares traditional follow-up of gynaecological cancer patients to an alternative
      follow-up model. In the alternative follow-up model the patients will meet a nurse at every
      second consultation. The nurse will focus on psychosocial health and educate the patients in
      the use of a study specific smartphone-application.

Detailed Description

      The goal is to improve follow-up of past and present cancer patients to have the best quality
      of life possible, despite having a serious illness. Todays' survivors differ from the
      survival population for whom the traditional follow-up was designed. Improvements in
      treatment assure that many cancer patients survive longer after diagnosis often with
      age-related comorbidities. Consequently, new evidence-based models for follow-up after cancer
      treatment with focus on techniques to improve coping with and management of late effects
      without increasing the costs are warranted. The chronic care model, which uses
      self-management interventions, is used for many chronic diseases-such as diabetes and asthma
      and is a valid model to consider for cancer follow-up care(1). Another relevant model is the
      risk stratified model where patients are stratified into low, moderate, or high-risk on the
      basis of expected recurrence rate and late-effects(2). Gynecological cancer patients
      constitute an underrepresented group in clinical cancer research.

      The research group has developed a follow-up model based on the principles of the
      risk-stratified model and the chronic care model with one or three year's hospital follow-up
      for low- versus medium/high-risk patients. Physicians will be replaced by nurses in 50% of
      the consultations. The nurses will use evidence-based behavior change techniques to coach the
      cancer patients on how to take an active role in management of their physical and mental late
      effects. These techniques will be further reinforced with a multifunctional smart
      phone-application (app). The "Lifestyle and Empowerment Techniques in Survivorship of
      Gynecologic Oncology-app" (LETSGO-app) has three main functions: 1) Self-evaluated symptoms
      (on recurrence or late effects) regularly reported through the app; 2) Targeted information
      on treatment, signs of recurrence, and late-effects on each cancer type and 3) Facilitation
      of early rehabilitation through physical activity instructions, goal-setting and electronic

      The investigators will conduct a multicenter study including 754 cancer survivors in Norway.
      Ten Norwegian hospitals will participate whereof five hospitals are intervention hospitals
      and five are control hospitals.

Study Type


Primary Outcome

Patients' score on the Health Education Impact Questionnaire (HEI-Q)

Secondary Outcome

 Patients' score on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), measuring ´Health related quality of life (HRQL)


Gynecologic Cancer


LETSGO follow-up

Study Arms / Comparison Groups

 Intervention arm
Description:  New follow-up model


* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status


Estimated Enrollment


Start Date

November 18, 2019

Completion Date

December 31, 2030

Primary Completion Date

December 31, 2024

Eligibility Criteria

        Inclusion Criteria:

          -  Histologically verified gynaecological cancer

               1. Cervical cancer restricted to squameous cell carcinoma, adeno carcinoma and
                  adeno-squameous carcinoma) or

               2. Endometrial cancer or

               3. Ovarian cancer (restricted to epithelial type) or

               4. Vulvar cancer

          -  Must have completed primary treatment and scheduled to follow-up

        Exclusion Criteria:

          -  Participating in other cancer treatment trial or follow-up trial

          -  Cervical cancer patients treated with trachelectomy

          -  On maintenance therapy

          -  Dementia or other mental/cognitive impairment

          -  Illiterate in Norwegian




18 Years - N/A

Accepts Healthy Volunteers



Ingvild Vistad, MD, PhD, 97532316, [email protected]

Location Countries


Location Countries


Administrative Informations



Organization ID


Responsible Party

Principal Investigator

Study Sponsor

Sorlandet Hospital HF


 University of Agder

Study Sponsor

Ingvild Vistad, MD, PhD, Principal Investigator, Sorlandet Hospital HF

Verification Date

July 2021